The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies

Roodenrijs, NMT; de Hair, MJH; Wheater, G; Elshahaly, M; Tekstra, J; Teng, YKO; Lafeber, FPJG; Hwang, CC; Liu, XY; Sasso, EH; van Laar, JM

Roodenrijs, NMT (reprint author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Heidelberglaan 100, NL-3508 GA Utrecht, Netherlands.

ARTHRITIS RESEARCH & THERAPY, 2018; 20 ():

Abstract

BackgroundA multi-biomarker disease activity (MBDA) score has been validated as an objective measure of disease activity in rheumatoid arthritis (RA) ......

Full Text Link